) The University of Wisconsin is a world renowned cancer research institution in clinical, translational, and basic cancer research. With its strong Comprehensive and McArdle Cancer Centers, Biostatistical Department, General Clinical Research Center, and K30 NIH Clinical Investigator Preparatory Program (CIPP) Award, it is in an excellent position to train physician investigators for academic careers in clinical oncology research. The objectives of the UW Academic Clinical Oncologist Training Program are to: 1) Provide a rigorous mentoring and didactic program in oncology, biostatistics, ethics, communication, and regulatory issues; 2) Develop academic leaders in tumor-type specific research; and, 3) Draw upon the considerable UW campus wide resources in basic and translational research, so as to foster an understanding of basic oncology research that will lead to future interdisciplinary collaborations in translational research. Participants in this program will receive at least two years of training that will be centered around one of the following disease sites: lung cancer, genitourinary neoplasms, breast cancer, GI malignancies, melanoma, gynecological oncology, head and neck cancers, CNS tumors, pediatric oncology, and hematology. Trainees will: 1) Be exposed to and participate in all aspects of clinical cancer research; 2) Participate in clinical rotations relevant to a specific disease site, so as to develop an expertise in a specific tumor type; 3) Develop and conduct an individual clinical research project; 4) Participate in basic and translational research activities; and 5) Take formal course work in biostatistics, ethics, leadership skills, scientific writing, and clinical trials methodology (this program will be individualized to the needs of the trainee, and be designed in conjunction with the UW CIPP). Applicants will be primarily drawn from national and UW training programs in Medical Oncology, Radiation Oncology, Pediatric Oncology, Hematology, and Surgical Ontology. Three traineeships will be awarded per year. All trainees will work closely with a clinical and basic scientist faculty mentor in their chosen disease specific site. The training program will be supervised by an Advisory Committee and a Special Mentoring and Advisory Committee for Women and Minority Trainees, that will monitor the trainees' progress and participate in the selection process.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
5K12CA087718-03
Application #
6522896
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lei, Ming
Project Start
2000-09-15
Project End
2005-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
3
Fiscal Year
2002
Total Cost
$391,285
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Tucholka, J L; Jacobson, N; Steffens, N M et al. (2018) Breast cancer survivor's perspectives on the role different providers play in follow-up care. Support Care Cancer 26:2015-2022
Neuman, Heather B; Schumacher, Jessica R; Schneider, David F et al. (2017) Variation in the Types of Providers Participating in Breast Cancer Follow-Up Care: A SEER-Medicare Analysis. Ann Surg Oncol 24:683-691
Neuman, Heather B; Jacobs, Elizabeth A; Steffens, Nicole M et al. (2016) Oncologists' perceived barriers to an expanded role for primary care in breast cancer survivorship care. Cancer Med 5:2198-204
Neuman, Heather B; Steffens, Nicole M; Jacobson, Nora et al. (2016) Oncologists' Perspectives of Their Roles and Responsibilities During Multi-disciplinary Breast Cancer Follow-Up. Ann Surg Oncol 23:708-14
Neuman, Heather B; Rathouz, Paul J; Winslow, Emily et al. (2016) Use of a novel statistical technique to examine the delivery of breast cancer follow-up care by different types of oncology providers. J Eval Clin Pract 22:737-44
Carlson, Anna R; Nomellini, Vanessa; Neuman, Heather B (2014) Importance of high clinical suspicion in diagnosing a Marjolin's ulcer with an unusual presentation. Am Surg 80:E61-2
Schmocker, Ryan K; Caretta-Weyer, Holly; Weiss, Jennifer M et al. (2014) Determining breast cancer axillary surgery within the surveillance epidemiology and end results-Medicare database. J Surg Oncol 109:756-9
Glarner, Carly E; Greenblatt, David Y; Rettammel, Robert J et al. (2013) Wound complications after inguinal lymph node dissection for melanoma: is ACS NSQIP adequate? Ann Surg Oncol 20:2049-55
Argiris, A; Kotsakis, A P; Hoang, T et al. (2013) Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck. Ann Oncol 24:220-5
Mohindra, Pranshu; Neuman, Heather B; Kozak, Kevin R (2013) The role of radiation in retroperitoneal sarcomas. Curr Treat Options Oncol 14:425-41

Showing the most recent 10 out of 37 publications